首页> 外文OA文献 >535MO BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma

【2h】

535MO BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma

机译：535Mo BGB-A333，一种抗PD-L1单克隆抗体，与Tislelizumab组合尿路上皮癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Martin Liberal; P.C. Fong; V. Moreno; S. Frentzas; J. Desai; T. Meniawy; B. Markman; M. Voskoboynik; N. Budha; J. Wu; W. Shen; M. Singh; E. Calvo;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma [J] . Izak Faiena, Amy L Cummings, Anna M Crosetti, Drug Design, Development and Therapy . 2018,第InaProgress期

机译：Durvalumab：用于治疗尿路上皮癌的研究性抗PD-L1单克隆抗体
2. Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) [J] . Austin Duffy, Sid P Kerkar, David E Kleiner, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：评估Tremelimumab（一种抗CTLA-4的单克隆抗体）联合消融治疗肝细胞癌（HCC）的初步研究的配对肿瘤活检分析和安全性数据
3. Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head [J] . Baselga J, Trigo JM, Bourhis J, Journal of Clinical Oncology . 2005,第24期

机译：抗表皮生长因子受体单克隆抗体西妥昔单抗联合铂类化学疗法在铂难治性转移性和/或复发性头颅癌患者中的II期多中心研究
4. An Envelop-Type Gene Nanocomplex with Encapsulated Monoclonal Antibodies for Target Therapy of Hepatocellular Carcinoma [C] . Wang Jinlei, Shen Jie, Hu Qinglian, World biomaterials congress . 2012

机译：信封型基因纳米复合物与封装的单克隆抗体对肝细胞癌的靶向治疗
5. Immunohistochemistry of carcinomas using monoclonal antibody, JAA-F11. [D] . Sridhar, Swetha. 2009

机译：使用单克隆抗体JAA-F11进行癌症的免疫组织化学。
6. Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma [O] . Izak Faiena, Amy L Cummings, Anna M Crosetti, 2018

机译：Durvalumab：用于治疗尿路上皮癌的研究性抗PD-L1单克隆抗体
7. Phase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) [O] . H.M. Babiker, I. Brana, D. Mahadevan, 2018

机译：Cemiplimab的阶段I扩增队列，一种人PD-1单克隆抗体，与放疗（RT），环磷酰胺和GM-CSF组合，患者（PTS），具有复发性或转移头和颈部鳞状细胞癌（R / M HNSCC ）

535MO BGB-A333, an anti-PD-L1 monoclonal antibody, in combination with tislelizumab in patients with urothelial carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅